DB
MEDS

Danske Bank’s DataMeds AI MEDS Stock Holding History

Danske Bank’s Portfolio MEDS Stock Details MEDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3 Buy
+1
New +$5 ﹤0.01% 1116

Other funds holding MEDS

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM

Danske Bank's MEDS Position: Q2 2026 in Review

Danske Bank opened a new position in DataMeds AI (MEDS) in Q2 2026: 1 share worth $3. The stake represents ﹤0.01% of the portfolio and ranks #1116 among its holdings.

9 funds tracked by Wall St. Rank hold MEDS as of Q2 2026.

  • Danske Bank held 1 share of DataMeds AI worth $3 as of Q2 2026.
  • DataMeds AI was a new Danske Bank position in Q2 2026.
  • DataMeds AI made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #1116 holding.
  • 9 funds tracked by Wall St. Rank held DataMeds AI as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.